Probe by former Special Counsel Jack Smith targets over 430 Republicans, raising concerns about political surveillance and partisan 'fishing expedition'.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Probe by former Special Counsel Jack Smith targets over 430 Republicans, raising concerns about political surveillance and partisan 'fishing expedition'.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
